According to the most recent clinical investigation, the probiotic strain SNZ 1969 efficiently manages the symptoms of IBS-D and IBS-C.

Sanzyme Biologicss (Telangana) (PRNewswire), Hyderabad, November 29, 1969 (Weizmannia coagulans SNZ 1969), is a natural spore-forming probiotic strain that has been shown to be effective at preventing IBS symptoms in five decades, as well as more than 30 human studies over a variety of age groups.Irritable bowel syndrome (IBS) is one of the most common intestinal dysfunctions, The conclusion of this study will be helpful to supplement manufacturers because it will help design products that fulfill the need of customers for natural alternative therapies for IBS, as well as the development of scientific and clinical data proving the effectiveness of probiotics.In a randomized, double blind, placebo-controlled study, a significant decrease in the GSRS IBS score was observed in subjects with constipation predominant irritable bowel syndrome (IBS-D), according to a statistically examined study.SNZ 1969 was well-tolerated and demonstrated a dramatic reduction of IBS-associated clinical symptoms relative to a placebo, and improved the Quality of Life of IBS patients.This study was performed at Apollo Hospitals, Hyderabad, India, and published in the International Journal of Basic & Clinical Pharmacology.

In a GI discomfort study, a major improvement was found in total SODA scores, which included symptoms such as burpingbelching, bloating, heartburn, passing gas, nausea, bad breath, and sour taste, as SNZ 1969 enters the colon intact and improves intestinal motility and gut microbiota composition.Sanzyme Biologics has carved its niche in probiotics for the past five decades by producing scientifically tested and well-documented probiotic strains that have extended beyond human health to aqua, veterinary, poultry, and bioremediation.Sanzyme Biologics has a market presence in over 40 countries.To learn more, visit or contact info@sanzymebiologics.com.

: +91-40-48589999 ext